Found 59 result(s) FROM 1963 pages containing the term 'lifestyle physical activity'.
Friday Apr 02, 2010
Spotlight on Sjögren's Syndrome
As many as 4 million Americans are affected by the autoimmune disorder, but most suffer from symptoms for 3 or more years before receiving an accurate diagnosis...
Wednesday Mar 31, 2010
Fibromyalgia Symptoms May be Alleviated by Short Bursts of Physical Activity
Lifestyle physical activity intervention may reduce fibromyalgia symptoms and improve physical function...
Thursday Feb 25, 2010
Physical Inactivity and Obesity Raises Arthritis Risk, Especially in Women
Arthritis rates are higher in the US than in Canada, according to a new study...
Monday Sep 21, 2009
RA Gene Screening Almost Ready for Primetime
Genetic screening for rheumatoid arthritis risk is not yet clinically useful, but combining five confirmed RA loci may provide an accurate predictive test...
Tuesday May 12, 2009
Obesity, Arthritis Blamed for Disability in Women
Females are at greater risk of obesity and arthritis than their male counterparts and these disabling conditions begin early and can rob women of their quality of life...
Thursday Jan 29, 2009
Bone Health in Men: Influencing Factors
According to the results of a bone health questionnaire, many men believe that they will not be affected by osteoporosis at all or as severely as women, and thus do not follow lifestyle recommendations to protect their bone mass…
Tuesday Jan 27, 2009
Bone Up on Depression, Osteoporosis Links
Depression and osteoporosis appear linked, perhaps by neuroendocrine dysfunction...
Monday Nov 17, 2008
Vitamin D Levels Linked to OA Cartilage Loss, OA Pain, and SSc Disease Activity by ACR Researchers
Low vitamin D levels are associated with faster progression of joint damage, bone loss, and pain in OA and with higher levels of inflammatory markers and vascular complications in systemic sclerosis, suggesting that more attention to vitamin D supplements might be in order...
Tuesday Oct 28, 2008
Rheumatology Experts Say Stopping Smoking May Cut RA Pain, Disease Activity
Researchers at two major medical meetings are highlighting the role smoking plays in chronic pain and disease activity in RA...
Friday Oct 03, 2008
Occupational Therapy May Help OA Patients Get Moving
Occupational therapy may help get patients with knee and hip osteoarthritis (OA) lead more active lives…
Tuesday Sep 30, 2008
Microparticles May Be Big Players in Systemic Scleroderma Disease Activity
Microparticles—small, membrane, coated vesicles—found in the blood of systemic scleroderma patients might not be inert debris…
Monday Sep 22, 2008
Body Fat Increases CRP in Women With RA, May Lead to Wrong Diagnosis of Persistent Synovitis
High levels of adipose tissue, especially in the midsection, are associated with high CRP levels in women with RA. Elevated CRP levels in overweight patients might not be an indication that more aggressive RA treatment is needed...
Thursday Jun 19, 2008
Baminercept shows good safety, substantial activity against RA in phase II data reported at EULAR
Baminercept alfa, a novel lymphotoxin β-receptor blocker, showed promising safety and efficacy in phase II data reported at EULAR...
Monday Jun 16, 2008
Belimumab is Back: New Criteria Show Activity in SLE
The humanized monoclonal antibody belimumab showed significant activity in the extension of a phase II clinical trial for SLE as measured by new, FDA-approved assessment criteria...
Tuesday May 13, 2008
More than Half of US Diabetics Have Arthritis
Arthritis afflicts more than half of diabetes patients in the US, making exercise difficult…
Tuesday May 06, 2008
Younger People Getting Joint Replacements to Restore Active Lifestyles
A better understanding of joint mechanisms and new technologies allow younger adults to relieve pain with joint replacements…
Wednesday Apr 02, 2008
DEXA Scans, Serum Testosterone, Vitamin D Tests Urged for Men Over 70
Osteoporosis in men is a common problem and requires more aggressive diagnosis, treatment, and monitoring of response...
Monday Mar 24, 2008
Should RA Patients Go Vegan?
A gluten-free, vegan diet may improve RA patients’ cardiovascular risk profile…
Monday Mar 10, 2008
AAOS Panel Presents Hip Resurfacing as Option for Some Younger Patients
Hip resurfacing may emerge as a preferred option for some younger arthritis patients...
Thursday Jan 31, 2008
Alendronate Decreases TRACP 5b Activity in Osteoarthritic Bone
Bisphosphonates may reduce TRACP 5b activity in the intertrochanteric area of the femoral head, suggesting that they are most effective in areas of well-supplied bone...
Friday Jan 25, 2008
Low Serum Testosterone Predicts Fracture Risk in Older Men
Men with serum testosterone <294 ng/dL have a significantly increased risk of nontraumatic fracture and should be referred for bone density assessment...
Wednesday Jan 16, 2008
Incyte Reports INCB18424, a Selective JAK2 Inhibitor, Shows Initial Positive Clinical Activity With Rapid Onset of Action in RA and Psoriasis
Incyte Corp announced positive clinical proof-of-concept results with its wholly-owned, internally developed, lead JAK2 (Janus-associated kinase 2) inhibitor, INCB18424, in rheumatoid arthritis (RA) and psoriasis...
Wednesday Jan 09, 2008
Personalized Exercise Prescriptions Warranted in RA
Individually-tailored exercise programs taking a patient's specific needs and abilities into account should become a standard part of rheumatoid arthritis (RA) treatment. Such programs can help reverse joint damage and reduce cardiovascular risk factors in this population...
Thursday Nov 29, 2007
New Method Provides Quick Estimate of 5-Year Hip Fracture Risk
A new algorithm based on 11 clinical factors can predict 5-year risk for hip fracture in postmenopausal women...
Thursday Nov 08, 2007
Centocor, Schering-Plough's Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of AS in Phase III Study; Monthly Treatment Yielded Marked Improvements in Physical Function
Centocor, Inc, a wholly owned subsidiary of Johnson & Johnson, announced that more than half of patients receiving monthly subcutaneous injections of golimumab 50 mg and 100 mg experienced significant and sustained improvements in the signs and symptoms of active ankylosing spondylitis (AS), according to the phase III study (GO-RAISE trial) results...
Wednesday Sep 05, 2007
Rheumatologists Asked to Take Lead in Reducing Cardiovascular Risk in RA Patients
The chronic inflammation that characterizes many rheumatoid diseases is thought to be one cause of the higher rates of cardiovascular disease (CVD) that afflicts these patients. Experts say not enough is being done to educate patients with rheumatoid arthritis (RA) or with systemic lupus erythematosus (SLE) about the importance of early CV protection, and that early education is critical—before clinically apparent CVD is detectable...van Leuven SI, et al. Rheumatology. 2007; rheumatology/kem202 [Epub ahead of print]; John H, et al. Rheumatology. 2007; doi:10.1093/rheumatology/kem176 [Epub ahead of print].
Monday Jul 23, 2007
Is "Tech Neck" the Latest Casualty From Excessive Blackberry Use?
Rheumatologists and orthopaedists may be seeing an influx of patients complaining of neck pain caused by tilting their heads to use cell phones, BlackBerry devices, iPods, or handheld games.
Thursday Jun 28, 2007
RA Disease Activity Decreases During Pregnancy, but Less Than Was Assumed
A prospective study of RA outcomes during pregnancy shows that improvement and remission rates are not as high as previously reported…
Friday Jun 15, 2007
Two Thirds of Gout Patients Receiving No, or Not Enough Treatment
A number of new treatment options for gout are available, but the major clinical problem is that even after gout diagnosis, only about one third of patients receive urate-lowering therapy...
Friday Jun 15, 2007
First Phase III Tocilizumab Data Show Rapid Improvement in RA Disease Activity, Confirming Critical Role of IL-6
Results of the first phase III trial of tocilizumab show that the anti-IL-6 monoclonal combined with methotrexate produces fast, sustained improvements in RA signs and symptoms, including a notable number of DAS28 remissions...
Thursday Jun 07, 2007
High Plasma Homocysteine Predicts Hip Fracture
Elevated plasma total homocysteine (tHcy) may be a modifiable risk factor for osteoporotic hip fracture...
Thursday May 10, 2007
Hydrotherapy, Tai Chi May Be Better Than Traditional Land-Based Exercises for OA
Hydrotherapy and Tai Chi are both better at improving physical function in OA patients than traditional exercise programs, and hydrotherapy has a particularly high patient adherence, perhaps because it seems to provide greater pain relief...
Tuesday May 08, 2007
2-Year Results Support Use of New Chondrocyte Graft to Repair Knee OA Damage
Two-year follow-up of a new 3-dimensional scaffold that permits grafting of autologous chondrocyte to repair knee cartilage defects show promising results in both knee OA and knee trauma, and the procedure can be done arthroscopically...
Tuesday Mar 13, 2007
Less Use of Diuretics, Earlier Hypouricemic Therapy Urged In Renal Transplant Patients At Risk for Recurrent Gout
Up to 23% of renal transplant recipients develop gout posttransplant but most are not getting hypouricemic therapy, even when they report recurrent gout attacks...
Thursday Mar 08, 2007
Stroke Specialists Urge More Attention to Hyperlipidemia, Hypertension, Baseline Lupus Activity as Predictors for Stroke
An 8-year longitudinal study of 238 lupus patients targets baseline SLE activity, hyperlipidemia, and hypertension as predictors of severe ischemic strokes and recommends aggressive intervention...
Tuesday Feb 27, 2007
UCB Reports Significant Reduction in Joint Damage From Phase III Results With Cimzia in Rheumatoid Arthritis; Fc Region Present in Conventional Anti-TNFs Is Not Required for Activity
UCB, a global biopharmaceutical company, announced results of an international, multicenter, placebo-controlled phase III study (RAPID 1) involving nearly 1000 patients that evaluated the investigational agent Cimziaâ„¢ (certolizumab pegol)...
Tuesday Jan 16, 2007
FDA Sets New Rule on Calcium/Vitamin D Osteoporosis Claims for Food, Diet Supplement Labeling
The FDA will permit a new "calcium plus vitamin D" claim in food and dietary supplement labeling for reducing the risk of osteoporosis and will shorten the required label in the hope that more dairy, juice, and other products that qualify will put it on their packaging, thus increasing consumer awareness...
Monday Sep 25, 2006
Rituximab Quickly Reduces Disease Activity in Treatment-Resistant RA
Rituximab added to methotrexate significantly reduces disease activity in patients whose RA is resistant to TNF inhibitors... Cohen SB, et al. Arthritis Rheum. 2006;54:2793-2806.
Wednesday Aug 09, 2006
Low Estrogen Levels Increase Risk of Knee OA in Women
Low concentrations of estradiol and urinary 2-hydroxyestrone may increase the risk of developing knee osteoarthritis among women approaching menopause... Sowers MFR, et al. Arthritis Rheum. 2006;54:2481-2487.
Wednesday Jul 19, 2006
Metabolic Syndrome Correlates With High Disease Activity in RA
Metabolic syndrome correlates with higher disease severity in RA. Karvounaris SA, et al. Ann Rheum Dis; published online June 22, 2006.
Tuesday Jun 27, 2006
Entremed's 2ME2 Demonstrates Antiangiogenic Activity in Rat Model of Chronic Autoimmune Inflammatory Joint Disease
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of inflammatory diseases and cancer, announced the presentation of preclinical data for its lead compound, 2-methoxyestradiol (2ME2), in rheumatoid arthritis (RA)....
Thursday Jun 22, 2006
EULAR Lupus Guidelines Make the Best of Sparse Data
While EULAR experts agree on the best treatment of SLE and recommend an integrated approach to medical care, the lupus task force also warns of a worrying lack of evidence on the benefits of lifestyle modifications and the impact of primary preventive measures... Boumpas D. 2006 EULAR Meeting.
Tuesday May 02, 2006
Exercise, Weight Loss Can Reverse Frailty in Obese Elderly
Diet-induced weight loss and exercise training can significantly strengthen and protect obese older adults and should be considered primary therapy in frail obese older patients... Villareal DT, et al. Arch Intern Med. 2006;166:860-866.
Tuesday Mar 07, 2006
High, Prolonged Inflammatory Activity in Rheumatoid Arthritis Increases Lymphoma Risk
The severity of disease, not its treatments, is a risk factor for the development of malignant lymphomas in rheumatoid arthritis patients... Baecklund E, et al. Arthritis Rheum. 2006;54:692-701.
Tuesday Feb 14, 2006
Disease Activity and Severity Seen as Determinants in Starting Tumor Necrosis Factor-Alpha Blockers in Ankylosing Spondylitis Prior to Publication of ASAS Recommendations
Both disease activity and severity were determinants in starting tumor necrosis factor-alpha blockers in ankylosing spondylitis patients prior to the publication of the 2003 Assessment in AS (ASAS) international working group recommendations... Pham T, et al. Ann Rheum Dis [serial online]. February 7, 2006; doi:10.1136/ard.2005.042630
Monday Oct 31, 2005
Regular Physical Activity May Strengthen Knee Cartilage
A novel magnetic resonance imaging technique used in a new study suggests that human articular cartilage can adapt to physical load, and that modest exercise improves knee cartilage glycosaminoglycan content in patients at risk for developing osteoarthritis … Roos EM, Dahlberg L. Arthritis Rheum. 2005;52:3507-3514.
Monday Oct 03, 2005
Acologix's AC-100 Shows Positive Preclinical Activity for Bone and Dental Applications
Acologix, Inc, of Hayward, California, a privately held biopharmaceutical company targeting bone and kidney diseases, presented preclinical data...
Tuesday Sep 20, 2005
Link Between Genetic Factors and Osteoporotic Fractures in the Elderly
The predisposition for osteoporotic fractures is stronger than has been previously estimated, especially for early occurring fractures. A search for genes and gene-environmental interactions that affect early osteoporotic fracture risk is likely to be beneficial, but fracture-prevention should be focused on lifestyle habits...Michaëlsson K, et al. Arch Intern Med. 2005;165:1825-1830.
Wednesday Aug 10, 2005
Abatacept Reduces Disease Activity and Improves Function in RA Patients Who Failed MTX
Results of a 12-month study show that the first in a class of agents designed to block a costimulatory pathway required for optimum activation of T cells may play an important role in the treatment of rheumatoid arthritis (RA), particularly among patients unresponsive to methotrexate (MTX)... Kremer JM, et al. Arthritis Rheum. 2005;52:2263-2271.
Friday Jul 08, 2005
Weight Loss Reduces Knee Joint Load
Losing just one pound results in a four-fold reduction in knee joint load in overweight and obese patients with OA of the knee... Messier SP, et al. Arthritis Rheum. 2005;52:2026-2032.
Wednesday Jun 22, 2005
Early Ankylosing Spondylitis Cohort Underscores Link Between Sustained Disease Activity and Progression
German Spondyloarthritis Inception Cohort (GESPIC) shows that sustained high disease activity during the early stages of AS, despite treatment with NSAIDs, may be an important prognostic indicator of disease progression, and may suggest a possible earlier role for TNF-blockade... Presented at: European Congress of Rheumatology of EULAR; June 8-11, 2005; Vienna, Austria.
Friday Jun 10, 2005
Experts Discuss the Interaction Between Environmental and Genetic Risk for RA
A noted epidemiologist and rheumatologist review the multifactorial interplay between the unmodifiable genetic component of the disease and environmental risk factors that account for approximately 50% of RA incidence, and suggest that certain lifestyle modifications may lower RA risk...Presented at: Annual European Congress of Rheumatology of EULAR; June 8-11, 2005; Vienna, Austria.
Thursday May 12, 2005
More Evidence for Cardiovascular Risk Among Selective and Nive Nonsteroidals
Several weeks after the US Food and Drug Administration called for sweeping changes to the labels of prescription and over-the-counter NSAIDs reflecting a potential cardiovascular risk, a Danish study confirms that they increase the chances of hospitalization for MI...Johnsen SP, et al. Arch Intern Med. 2005;165:978-984.
Tuesday Apr 26, 2005
American College of Rheumatology Responds to the Recent FDA Action on NSAIDs
Citing a lack of evidence implicating OTC and prescription NSAIDs in CV risk, the American College of Rheumatology criticized aspects of the recent FDA decision... American College of Rheumatology letter to Lester M. Crawford, DVM, PhD, acting commissioner of the FDA. April 21, 2005.
Thursday Mar 24, 2005
Residencies in Orthopaedic Surgery and Other Specialties Remain Competitive in 2005 Match
The National Resident Matching Program reported a record year for the number of first-year residency positions and the number of positions filled.
Tuesday Jan 18, 2005
One-Third of US Adults Including Growing Numbers of Arthritis Patients Turn to Complementary and Alternative Medicine
In response to continued use of these products, rheumatologists are urged to become more aware of nonprescription medications and drug-herb interactions...Tindle HA. Altern Ther Health Med. 2005;11:42-49.
Monday Dec 13, 2004
Synovial Tissue Interleukin-18 Expression Correlates With Inflammatory Arthritis Disease Activity
New study underscores the important proinflammatory role of IL-18 in the pathophysiology of inflammatory arthritis, and suggests that treatment that inhibits or neutralizes endogenous IL-18 may become an effective tool in controlling synovial tissue inflammation&Rooney T, et al. Ann Rheum Dis. 2004;63:1393-1398.
Thursday Oct 21, 2004
Researchers Outline Genetic and Environmental Triggers for Virulent Ankylosing Spondylitis
Genetic predisposition and a physically demanding job affect extent of disability that will accompany the inflammatory disease... Ward MM, et al. Presented at: Annual Meeting of the American College of Rheumatology; October 20, 2004; San Antonio, Tex.
Monday Aug 30, 2004
Studies Point to Genetic Susceptibility for Knee Osteoarthritis
(Neame RL, et al. Ann Rheum Dis. 2004;63:1022-1027; Valdes AM, et al. Arthritis Rheum. 2004;50:2497-2507.)
|